DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study

Date
2019
Author
Fung, Adrian Tien-Chin
Busch, Catharina
Iglicki, Matias
Rehak, Matus
Goldstein, Michaella
Cebeci, Zafer
Loewenstein, Anat
Zur, Dinah
Okada, Mali
Mariussi, Miriana
Chhablani, Jay Kumar
Fraser-Bell, Samantha
Chaikitmongkol, Voraporn
Couturier, Aude
Giancipoli, Ermete
Lupidi, Marco
Rodriguez-Valdes, Patricio J.
Metadata
Show full item record
Abstract
Purpose: To investigate efficacy and safety of repeated dexamethasone (DEX) implants over 24 months, in diabetic macular edema (DME) eyes that were treatment naive compared with eyes refractory to anti-vascular endothelial growth factor treatment, in a real-life environment.
URI
http://hdl.handle.net/20.500.12627/162850
https://doi.org/10.1097/iae.0000000000002196
Collections